1. Common clinic scenarios

'Doctor, I'm 56, my cataract is getting bad enough to operate. I've worn glasses for ~2.0 D of astigmatism for years. After surgery, can I get rid of glasses? I've heard about a so-called toric IOL that costs an extra NT$ 40,000-plus per eye out-of-pocket. Is it worth it?'

'Doctor, I had LASIK years ago and now have cataracts at 60. I've heard that post-LASIK cataract surgery is more complicated and less predictable. Can I still get a toric IOL?'

'Doctor, I have mild keratoconus and have worn RGP contacts for years. I'm starting to get cataracts. Can I have cataract surgery? Which IOL?'

All three scenarios involve toric IOLs. The first is the standard one; the second and third are 'special populations' where toric IOLs remain feasible but require extra workup. A June 2026 narrative review in American Journal of Ophthalmology (Verstraaten et al., a group of European cataract experts) synthesizes the past decade of toric IOL evidence — from basic indications and preoperative measurements to formulas, rotational stability, and these special populations — and is among the most thorough English-language reviews to date. This article digests its main points in clinic-friendly language and adds the Taiwan-specific NHI/self-pay reality.

2. Common patient Q&As

Q1: 'I have astigmatism — do I have to get a toric IOL with cataract surgery?'

A: No. International consensus is to consider a toric IOL when regular corneal astigmatism is ≥ 1.0 D AND the patient wants to be as spectacle-free as possible; the benefit is clearest above 1.5–2.0 D. Below 0.75 D, a standard monofocal usually suffices; 0.75–1.0 D is a grey zone — toric, monofocal + LRI, or monofocal + post-op glasses all valid. In Taiwan you pay a difference out-of-pocket (typically ~NT$ 45,000 per eye for a monofocal toric); discuss budget, lifestyle (night driving? reading? sports?) and your tolerance for glasses with your surgeon.

Q2: 'Is toric IOL better than LRI or FSAK?'

A: By the 'residual astigmatism < 0.5 D' metric, toric IOLs do better. Cochrane 2019 (Lake et al., 10 RCTs, 626 eyes in total): toric ~70% reached < 0.5 D, LRI ~50%; mean residual cylinder ~0.3 D lower with toric, although the authors judged this difference likely clinically unimportant and found no important difference in visual acuity or quality of life. The Yen 2025 meta-analysis (9 studies, 590 participants) also found slightly less residual cylinder with toric than with FSAK (~0.17 D less on average) and slightly better UDVA, but no included study exceeded 4.5 D and results were not compared by astigmatism level; the Zheng 2023 meta-analysis (5 comparative studies, 336 eyes) was similar: ~0.19 D less residual cylinder with toric than with FSAK and no statistically significant UDVA difference; the authors suggested the gap narrows as preoperative astigmatism decreases, but too few studies were available to confirm this by subgroup analysis. LRI/FSAK pros: no extra IOL cost, can add onto a standard IOL. Cons: less correction power, less stable, can regress. Toric pros: accurate and stable correction. Cons: higher cost, demands precise intraoperative alignment, very rarely needs repositioning (~0.65%).

Q3: 'Will the toric IOL rotate? What if it does?'

A: Yes, but clinically significant rotation is uncommon. Modern toric IOLs stay within ±5° of target in 90–97% of eyes; ~0.65% need repositioning surgery (Oshika et al. 2018, 6,431-eye registry). Each 1° off-axis costs ~3.3% of the cylinder correction; > 10° usually warrants repositioning. Repositioning is usually done within 1 to a few weeks after surgery (about 10 days on average in Oshika's study) — too early (1–2 days) and it tends to re-rotate; too late and capsular fibrosis makes adjustment harder. Repositioning can still have complications; discuss the details with your surgeon. Strategies to reduce rotation: choose the right IOL design (hydrophobic acrylic with appropriate haptic), precise intraoperative alignment (image-guided systems outperform manual ink marking), thorough OVD removal, appropriately sized capsulorhexis.

Q4: 'Can I still get a toric IOL after past LASIK/SMILE/PRK?'

A: Yes, but calculations are much more complex and results less predictable. Standard IOL formulas assume a normal anterior-to-posterior cornea ratio; refractive surgery has altered the anterior curvature, so standard formulas overestimate corneal power and create a hyperopic surprise. International consensus is to use post-refractive formulas: Barrett True-K Toric (uses direct posterior measurement), ASCRS Postrefractive Calculator, etc. With strict selection (regular bowtie pattern within central 3.0 mm, < 0.75 D difference between imaging techniques, axis difference < 15°), post-LASIK toric IOL implantation can yield good outcomes — but patients should be counseled that 'mild glasses or a future touch-up may still be needed.' See an ophthalmologist with explicit post-refractive cataract experience.

Q5: 'I have keratoconus — can I get a toric IOL?'

A: Yes, but with strict selection. International consensus: (1) stable ≥ 1 year (no recent progression or fresh crosslinking); (2) mild-to-moderate KC (refer severe KC for keratoplasty or RGP); (3) reproducible refraction; (4) KC-specific formulas (Barrett True-K KC P-PCA / M-PCA). Studies show selected patients gain significant UDVA and BCVA improvement; rotational stability matches the general population (especially hydrophobic acrylic IOLs). In highly myopic eyes, a capsular tension ring can further stabilize. Given the heterogeneity of KC, compare multiple formulas, and counsel patients that 'contacts or glasses may still be needed for full correction.'

Q6: 'Does Taiwan NHI cover toric IOLs? Roughly how much do they cost?'

A: Not fully — you pay a difference out-of-pocket. Taiwan's NHI drug coverage regulations don't include IOLs (IOLs are medical devices under separate 'special materials' regulations). Standard monofocal spherical IOLs are fully NHI-covered; toric/EDOF/multifocal/trifocal special-function IOLs are billed as 'NHI pays 2,744 points + patient pays the difference', and the cataract surgery itself remains NHI-covered. Per the NHIA self-pay-difference device price lookup (queried October 2026), the difference for an aspheric monofocal toric IOL is NT$ 45,000 per eye, and about NT$ 55,000–110,000 per eye combined with extended-focus or multifocal designs (full table in section 13); figures are for reference only — actual charges follow each hospital/clinic's posted fee schedule. Budget alternatives: (1) standard IOL + glasses with cylinder (fully NHI-covered, cheapest); (2) standard IOL + simultaneous LRI (offered at some centers). Don't choose 'upgrade' IOLs just because the name sounds premium — base your decision on your actual corneal astigmatism, lifestyle, budget, and an individualized discussion with your doctor.

Q7: 'After a toric IOL, will I still see halos, starbursts, glare?'

A: Depends on whether you choose monofocal toric or multifocal/EDOF toric. Monofocal toric: halo/glare similar to standard monofocal; negative dysphotopsia occurs in up to ~26% after surgery and persists at 1 year in about 0.13–3% (Pusnik et al. 2022). Multifocal toric: because light is split between foci, glare/halo is more common — in Visser et al. 2011, ~50% of patients reported moderate glare, halos or starbursts; most adapt and severe interference with night driving or daily life remains uncommon (< 5%). If you drive frequently at night, are light-sensitive, or need fine contrast sensitivity, discuss monofocal toric instead. Significant IOL decentration/tilt can also induce higher-order aberrations and glare — that's an alignment problem, not the lens itself.

Q8: 'Can I have laser touch-up after a toric IOL?'

A: Yes, but usually wait at least 3 months for refractive stabilization. If significant residual cylinder or sphere remains and the IOL is well aligned, options include: (1) corneal laser touch-up (LASIK enhancement, PRK) — for smaller residual errors; (2) IOL exchange after recalculation or a piggyback IOL — for larger errors; (3) abroad, the Light Adjustable Lens (LAL) allows postoperative UV-light power adjustment, but it must be implanted at the original surgery; no Taiwan MOHW license could be found, so it is not yet available in Taiwan. The original surgeon should evaluate any touch-up because they know the original alignment and IOL model best.

3. Key takeaways: 8 things you really need to know

30-second takeaways

Main indication: regular corneal astigmatism ≥ 1.0 D (benefit clearest > 1.5–2.0 D) + patient wants spectacle independence; < 0.75 D usually does not need a toric IOL, 0.75–1.0 D is a grey zone
Account for posterior corneal astigmatism (PCA): ignoring PCA can cause residual astigmatism error — PCA averages ~0.5 D in WTR eyes and ~0.3 D in ATR eyes, so anterior-only measurement tends to overestimate WTR and underestimate ATR astigmatism
Mainstream formulas: Barrett Toric, Abulafia-Koch (both have built-in PCA correction); Barrett True-K Toric for post-LASIK, Barrett True-K KC for keratoconus
Outperforms LRIs: Cochrane 2019 — toric IOL achieves residual astigmatism < 0.5 D in ~70% of eyes vs ~50% for LRIs; mean residual cylinder ~0.3 D lower
Rotation risk is manageable: 90–97% within ±5° of target; overall repositioning rate ~0.65% (6431-eye registry); each 1° off-axis = 3.3% lost correction
Special populations feasible but selective: post-LASIK (Barrett True-K Toric, strict selection), mild-to-moderate KC (stable ≥ 1 yr), post-keratoplasty (custom toric reports favourable), Fuchs/DMEK (over-correction common, use epithelial mapping); use caution in severe PEX
Self-pay difference in Taiwan: NHI fully covers standard monofocal spherical IOLs; toric/multifocal/EDOF IOLs are 'special materials' (not under the drug coverage regulations) — NHI pays 2,744 points and you pay the difference: typically ~NT$ 45,000 per eye for a monofocal toric and ~NT$ 110,000 for a trifocal toric (NHIA price lookup, October 2026)
Open questions: cost-effectiveness evidence is sparse, long-term ≥ 5-yr PROMs lacking, indications for irregular astigmatism remain ill-defined, image-guided vs manual marking health-economics analyses are limited

4. Astigmatism and cataract: background

Astigmatism means the eye's optical system has unequal refractive power along different meridians, so light cannot focus to a single point on the retina. The dominant source is corneal astigmatism (the cornea is ellipsoidal rather than perfectly spherical); a smaller contribution comes from the crystalline lens itself. Regular astigmatism is classified clinically by axis into three subtypes:

Scroll horizontally to read the table. With a keyboard, focus the table area and use the arrow keys.

Type	Steep axis	Features / epidemiology
With-the-Rule (WTR)	60°–120° (vertical steep)	Predominant in people under 40; the spectacle cylinder axis is perpendicular to the steep meridian, near 180° (minus-cylinder notation)
Against-the-Rule (ATR)	0°–30° / 150°–180° (horizontal steep)	Increases with age
Oblique	30°–60° / 120°–150°	Like ATR, increases with age

Regular vs irregular astigmatism: regular astigmatism has its steepest and flattest meridians perpendicular and can be corrected with a single cylinder power. Irregular astigmatism (keratoconus, trauma, scarring, severe dry eye) lacks this symmetry; a toric IOL cannot fully correct it, and rigid contact lenses or corneal procedures may be needed. Toric IOLs are designed for regular corneal astigmatism — distinguishing the two is a critical preoperative step.

Prevalence: astigmatism is one of the most common refractive errors worldwide. Hashemi et al.'s global meta-analysis: ~14.9% in children rising to 40.4% in adults (cylinder > 0.5 D threshold). Among cataract surgery candidates the rate is higher — Day et al. (UK) found ~42% have ≥ 1.0 D corneal astigmatism (the typical threshold for toric IOL consideration).

Posterior corneal astigmatism (PCA) matters: early IOL formulas used only anterior keratometric astigmatism (KA), assuming PCA was negligible. Koch et al. (2012) showed PCA is real and non-trivial — predominantly in the ATR direction:

WTR eyes: anterior is WTR + posterior is ATR → they partly cancel, so total corneal astigmatism (TCA) is ~0.5 D less than KA; using KA alone leads to overcorrection
ATR eyes: anterior and posterior point the same way → additive; TCA is ~0.3 D more than KA; using KA alone leads to undercorrection

That's why modern toric IOL calculation must use formulas that estimate or directly measure PCA (Barrett Toric, Abulafia-Koch). Neglecting PCA is an important source of postoperative residual astigmatism error.

5. Indications and exclusions: who's a candidate?

✅ Main indications (international consensus)

Regular corneal astigmatism ≥ 1.0 D (ESCRS 2024 recommendations: consider at ≥ 1.0 D, moderate evidence > 1.5 D, strong evidence > 2.0 D; 0.75–1.0 D is a grey zone, and many surgeons already correct from ≥ 0.75 D)
Patient wants to be as spectacle-free as possible (spectacle independence is part of the goal)
Consistent astigmatism magnitude/axis across imaging modalities (difference ≤ 0.5 D / ≤ 10°, indicating regular and reproducible)
Able to afford the out-of-pocket difference (not fully NHI-covered in Taiwan; typically ~NT$ 45,000 per eye for a monofocal toric) and accept the residual-astigmatism and very-low repositioning risks

⚠️ Relative contraindications / use with caution

Irregular astigmatism (severe keratoconus, surface-irregularity from severe dry eye, traumatic scarring, Salzmann nodular degeneration, severe corneal scarring) — toric IOL cannot fully correct higher-order aberrations
Progressing keratoconus (refractive change in past 12 months, or recent crosslinking) — unstable astigmatism makes calculation unreliable
Severe PEX with marked zonular instability — high risk of late dislocation, axis stability compromised
Unable to cooperate with precise preoperative measurements (severe dementia, unable to fixate)
Unrealistic expectations — patients expecting 'toric guarantees no glasses ever' will be disappointed

6. Preoperative workup SOP

Toric IOL accuracy hinges on preoperative measurement quality. The international consensus workup has five key elements:

Scroll horizontally to read the table. With a keyboard, focus the table area and use the arrow keys.

Step	Key content
① Ocular surface optimization	Dry eye, MGD, allergic conjunctivitis all disturb keratometry (K-readings 'fluctuate'). Optimize ocular surface 4–6 weeks before (artificial tears, warm compresses, short-course steroid/cyclosporine if needed). → 8 dry-eye myths
② Multi-device cross-check	Optical biometry (IOLMaster 700, Lenstar, Argos) + Pentacam/Scheimpflug ± anterior segment OCT. If ≥ 2 devices disagree by > 0.5 D magnitude or > 10° axis, the astigmatism is 'not regular enough' or measurement is unreliable — don't proceed with toric IOL directly
③ Include posterior corneal astigmatism (PCA)	Use Barrett Toric, Abulafia-Koch (built-in PCA estimation), or directly measure PCA via Pentacam/AS-OCT. PCA neglect is an important source of residual astigmatism error
④ Corneal topography review	Verify a regular bowtie pattern; irregular topographies (keratoconus, irregular post-LASIK, Salzmann's) need expert interpretation and usually special formulas or alternative plans
⑤ Expectation-setting	Honest counselling: (a) residual cylinder won't be zero, 70% reaching < 0.5 D doesn't mean 100%; (b) very rare need for repositioning; (c) multifocal toric carries halo/glare risk; (d) special risks in post-LASIK/KC; (e) Taiwan's self-pay-difference cost structure

7. IOL calculation formulas: which is most accurate?

Modern toric IOL formulas have proliferated. The Verstraaten review describes two approaches: (1) mathematical modeling from anterior corneal measurements (e.g., Barrett Toric, Abulafia-Koch); (2) direct measurement of total corneal astigmatism (TCA, e.g., Scheimpflug tomography or ray tracing). Post-refractive and keratoconic eyes are discussed separately. The table below groups representative formulas by use case:

Scroll horizontally to read the table. With a keyboard, focus the table area and use the arrow keys.

Category	Mainstream formulas	Use / features
Universal	Barrett Toric, Abulafia-Koch, Kane Toric, EVO Toric	Mainstream; all include PCA estimation. Multiple studies show Barrett Toric and Abulafia-Koch perform comparably across populations, both superior to earlier KA-only Holladay/SRK Toric
Post-refractive	Barrett True-K Toric, ASCRS Postrefractive Calculator	LASIK/PRK altered anterior curvature; standard formulas overestimate corneal power. True-K series corrects with direct posterior K. Run multiple formulas and compare for post-refractive eyes
Keratoconus	Barrett True-K KC (P-PCA / M-PCA), Kane KC, Hoffer-QST KC	KC has steep K (> 47 D); standard formulas tend to cause hyperopic surprises. KC-specific formulas improve prediction. Tian et al. 2025 network meta-analysis: Barrett True-K KC P-PCA and M-PCA ranked most accurate; multi-formula comparison recommended

Online IOL calculators and apps: modern surgeons use online calculators (Barrett Toric official site, ASCRS Online Calculator) or IOLMaster built-in systems; smartphone apps that assist toric axis marking exist (reviewed by Scantling-Birch et al. 2022) but supplement rather than replace clinical judgment.

8. Outcomes and patient-reported satisfaction

The Verstraaten review aggregates the past decade's key outcome studies. The three pivotal objective metrics are residual refractive astigmatism, UDVA, and spectacle independence:

Residual refractive astigmatism < 0.5 D rate: toric IOL ~70% (Cochrane 2019, Lake et al.); theoretical lower bound ~0.3–0.4 D due to cumulative measurement/SIA/alignment/manufacturing errors
UDVA: Kessel et al. 2016 meta-analysis (13 RCTs): UDVA better with toric than with non-toric IOLs (logMAR mean difference −0.07, less than one chart line); the 2024 American Academy of Ophthalmology technology assessment reached the same conclusion
Spectacle independence: monofocal toric IOLs give a higher chance of distance spectacle independence than non-toric IOLs (Kessel 2016); with multifocal toric IOLs, Visser et al. 2011 (25 patients) reported spectacle independence for distance in 95% and for near in 79%, at the cost of halos/glare

PROMs (patient-reported outcomes): common instruments include NEI-RQL 42, VFQ-25, Catquest-9SF. In Mencucci et al. 2013 (non-randomised prospective study, corneal astigmatism > 1.5 D, 40 patients per group), toric IOL patients scored significantly higher at 3 months than astigmatic patients given a standard monofocal IOL on the NEI-RQL 42 items 'clarity of vision', 'far vision', 'glare' and 'satisfaction with correction'. Verstraaten et al. flagged that long-term (≥ 5 yr) PROM data remain sparse — an important research priority.

Dysphotopsia is the most common patient complaint. Pusnik et al. 2022 review summarized:

Positive dysphotopsia (halos, starbursts, glare): up to 67% early postop; persistent at 1 year ~2%; rare need for surgical remediation (0.07%)
Negative dysphotopsia (peripheral arc shadow): acute ~26%; persistent long-term only 0.1–3%
Monofocal toric photic phenomena are similar to standard monofocals; halo/glare is more common with multifocal toric: in Visser et al. 2011 (25 patients, no control group) ~50% reported moderate glare, halos or starbursts

9. Toric IOL vs LRI vs FSAK: how to choose?

Three options for managing astigmatism at the time of cataract surgery: (1) Toric IOL — cylinder built into the IOL; (2) LRI (Limbal Relaxing Incisions) — paired arcuate cuts at the limbus releasing astigmatism; (3) FSAK (Femtosecond Laser-Assisted Astigmatic Keratotomy) — precise femto-laser arcuate corneal incisions. Evidence comparison:

Scroll horizontally to read the table. With a keyboard, focus the table area and use the arrow keys.

Comparison	Toric IOL	LRI (manual)	FSAK (femto)
Astigmatism range	From about 1.0 D; common brands up to 6.0 D, some up to 12.0 D	Low astigmatism (accuracy degrades at higher cylinder)	Low-to-moderate astigmatism (range varies by study)
Residual < 0.5 D rate	~70% (Cochrane 2019)	~50% (Cochrane 2019)	Neither meta-analysis (Yen 2025, Zheng 2023) reported < 0.5 D. Yen 2025 reported only ≤ 1.0 D: FSAK ~69% (65/94 pooled across 3 studies) vs toric IOL ~92% (84/91); Zheng 2023 reported only mean residual cylinder: ~0.19 D higher with FSAK than with toric IOL
Long-term stability	High; rare rotation can be repositioned	Moderate; may regress	Moderate-to-high; depends on equipment
Corneal health impact	None; cornea untouched	Small; possible mild epithelial defect	Small; more precise than LRI, may still delay epithelial healing
Cost (Taiwan)	High (out-of-pocket IOL difference, ~NT$ 45,000 per eye for a monofocal toric)	Low (some centers bundle, no extra fee)	Moderate-to-high (femto laser fee usually separate)

Practical guide: astigmatism > 1.5–2.0 D — clearest benefit from a toric IOL, which usually beats LRI/FSAK; 1.0–1.5 D — toric or LRI + standard IOL (or combined) are both reasonable; 0.75–1.0 D is a grey zone; < 1.0 D — LRI/FSAK as a cheaper option. FSAK has an edge in special populations requiring extreme alignment precision (post-LASIK) but at higher cost. Final decision is individualized.

10. Toric IOL design, material, and intraoperative alignment

The Verstraaten review highlights that IOL design and material significantly affect rotational stability. Key parameters: haptic shape, IOL diameter, material, and surface treatment:

Haptic design: plate haptic (board-like, ~11 mm diameter) vs C-loop haptic (~13 mm). Per Verstraaten et al.: C-loop is most common; plate designs rotate less in myopic eyes; double C-loop (quad-haptic) designs show the greatest rotational stability. Recent 'frosted haptic' surface treatment (e.g., Tecnis Toric II) significantly reduces rotation (mean absolute rotation < 1° at 3 months)
Material: (1) Hydrophobic acrylic — strong capsular adhesion, less rotation, and lower PCO than hydrophilic acrylic; current mainstream. (2) Hydrophilic acrylic — good foldability but slightly higher PCO and risk of lens calcification (opacification). (3) Silicone — less used; also low PCO, but slightly higher risk of postoperative infection (bacterial adhesion) and capsular bag injury (fast unfolding). (4) PMMA — rigid, needs large incision, higher PCO; mostly historical
Single-piece vs three-piece: modern toric IOLs are almost universally single-piece, more stable, with smaller incision (2.2 mm mainstream); three-piece designs reserved for sulcus implantation or special situations

Intraoperative alignment method is the make-or-break step. Per the Verstraaten review:

Scroll horizontally to read the table. With a keyboard, focus the table area and use the arrow keys.

Alignment method	Principle	Accuracy
Manual ink marking	Patient sitting upright, mark 0°/180° at limbus with ink, align with intraoperative gauge	Cheapest; accuracy limited by ink spread, positioning and surgeon's eye; larger axis error than image guidance
Image-guided digital systems (Verion, Callisto Eye, TrueGuide, etc.)	Preoperative iris/vessel image registered; intraoperative overlay on microscope view, auto-tracks	A meta-analysis of 6 RCTs found about 2° less axis error than manual marking (Yao 2024); Panagiotopoulou et al. 2019 systematic review also shows superior precision. Cost is the main limitation

3.3% lost correction per 1° off-axis is the consensus 'golden rule.' Translation: 5° off = ~17% lost, 10° off = ~33% lost, 30° off = zero correction, > 30° off = induces astigmatism in the opposite axis. Hence the emphasis on precise alignment: a 2024 meta-analysis by Yao et al. (6 RCTs) found smaller axis misalignment with image-guided than with manual marking, but no significant difference in the proportion of eyes with residual cylinder ≤ 0.5 D.

11. Rotational stability, repositioning timing, other complications

The literature on toric IOL rotational stability is now comprehensive. Key numbers:

Scroll horizontally to read the table. With a keyboard, focus the table area and use the arrow keys.

Study	Design	Key results
Hoffmann et al. 2025	Prospective RCT (15 centers, 299 eyes, 4 toric IOL models)	All models stable at 4–6 months; 90–97% within ±5° depending on model; only Tecnis (8.3%) and AT Torbi (4.3%) had lenses exceeding 10°; none with AcrySof or Vivinex
Lee and Chang 2018	Retrospective cohort (1273 eyes, single practice)	Day 1: 82–92% within ±5°; mean rotation 2.7° (AcrySof) vs 3.8° (Tecnis), both hydrophobic acrylic; 1.6–3.1% need repositioning
Oshika et al. 2018	Retrospective multicenter case series (6431 eyes)	0.65% (42/6431) needed repositioning; mean off-axis 33°; repositioned ~10 days postop on average; repositioning ≥ 7 days postop gave smaller final misalignment (6° vs 13° if earlier)

💡 Optimal timing of IOL repositioning

Too early (within 1–2 days): capsular bag has not started fibrosing, IOL can drift, prone to re-rotation
From about 1 week to a few weeks: initial capsular fibrosis 'locks in' the IOL post-repositioning; most cases are done in this window (about 10 days on average in Oshika's study)
Too late: harder once capsular fibrosis sets in, IOL hard to rotate, theoretical zonular stress risk
Safety of repositioning: possible adverse events include transient IOP elevation, CME, repeat dislocation, hemorrhage or inflammation, endothelial cell loss

Decentration and tilt: centration and planarity also matter. Clinically symptomatic decentration is uncommon if the capsulorhexis fully overlaps the IOL edge 360°. Mild decentration (< 0.5 mm) or tilt (< 5°) has minimal visual impact. Severe decentration may require recentration or exchange.

Postoperative behavior: traditional advice includes avoiding strenuous activity, sleeping face-down, or rubbing eyes for 1–2 weeks. But Jandewerth et al. 2025 (randomized, non-toric IOL) found that walking vs lying down in the first postoperative hour didn't affect IOL rotation. Toric-specific behavioral guidelines remain lacking; current advice mostly mirrors general post-cataract recovery.

12. Special populations

The review by Verstraaten et al. dedicates substantial space to special populations where toric IOLs remain feasible but require more careful preoperative assessment, special formulas, and managed expectations.

(1) Post-refractive surgery (LASIK / SMILE / PRK)

Standard keratometry overestimates corneal power (anterior surface altered by laser). Must use formulas using direct posterior measurement (Barrett True-K Toric) or the ASCRS online calculator, with strict selection criteria:

Regular bowtie pattern within central 3.0 mm zone
Magnitude difference ≤ 0.75 D across imaging modalities
Axis difference ≤ 15° across modalities
Multi-formula comparison; counsel that 'mild glasses or future touch-up may still be needed'

(2) Keratoconus

Criteria: (1) stable ≥ 1 year; (2) mild-to-moderate KC; (3) reproducible refraction; (4) use KC-specific formulas (Barrett True-K KC P-PCA/M-PCA, Hoffer-QST KC). In selected mild-to-moderate KC, toric IOLs significantly improve UDVA and BCVA; hydrophobic acrylic remains stable even in high myopia (consider capsular tension ring). Yahalomi et al. 2022 meta-analysis found generally satisfactory refractive outcomes in mild-to-moderate KC, with the Kane formula (keratoconus adjustment) giving the lowest prediction error. KC heterogeneity demands multi-formula and multi-device cross-validation.

(3) Pseudoexfoliation syndrome (PEX)

PEX makes cataract surgery harder: poorly dilating pupils, zonular instability, more postoperative inflammation. For toric IOLs the biggest issue is late spontaneous IOL dislocation — PEX is the leading cause, often within a decade of surgery. Dislocation equals total loss of axis alignment. PEX eyes are also prone to capsular phimosis, zonular weakening, and IOL decentration. Refractive surprise > 1.0 D is significantly more likely. Use toric IOL with caution; ensure informed consent.

(4) Post-keratoplasty (PK / DALK)

Wan et al. 2022 reviewed 20 studies (342 eyes, including phakic toric ICLs and iris-clipped IOLs); the cataract-surgery subset cited by Verstraaten comprises 7 studies and 106 post-keratoplasty eyes with toric IOL: refractive astigmatism reduced 52.5–74.6%; 50–100% achieved residual ≤ 1.0 D; UDVA ≥ 20/40 in 61.5–100%. Safety acceptable, only 1% needed rotation. Custom toric IOLs (personalized) maintain stability in PK/DALK with all alignments within ±10°. Endothelial cell loss 5.6–22.3%. Conclusion: in selected patients with custom toric, toric IOL is reasonable and effective post-keratoplasty.

(5) Fuchs endothelial dystrophy + triple DMEK

In FECD patients needing both cataract surgery and endothelial keratoplasty (e.g., DMEK), triple DMEK (cataract + toric IOL + DMEK in one operation) is an option. Yokogawa 2017, Trindade 2021 show favorable outcomes, with UDVA slightly inferior to standard cataract. Challenge: overcorrection is common in WTR eyes because residual posterior ATR persists. Recommendations: (1) combine biometric data and toric calculator outputs; (2) add AS-OCT epithelial mapping; (3) temporal incision; (4) re-verify IOL alignment after DMEK graft fixation; (5) implanting toric IOL before clinical corneal edema may improve predictability.

13. Taiwan context: NHI vs self-pay structure

⚠️ Important: toric IOLs need an out-of-pocket difference in Taiwan (not fully NHI-covered)

Taiwan NHI's drug-coverage rules do not include IOLs — IOLs are medical devices under a separate 'special materials' framework. Toric IOLs are self-pay-difference items: NHI pays 2,744 points toward the lens and you pay the difference; the cataract surgery itself is NHI-covered. Actual charges follow your hospital/clinic's posted fees and pre-service explanation.

Standard monofocal spherical IOL: fully NHI-covered, no out-of-pocket cost (surgery fee + standard lens)
Toric / multifocal / EDOF / trifocal IOLs: out-of-pocket difference (priced as 'NHI portion + patient pays the difference')
National reference prices: about NT$ 45,000 (aspheric monofocal toric), NT$ 85,000 (trifocal) and NT$ 110,000 (trifocal toric) per eye; see the table below for every class

Special-function IOLs: national reference prices

National figures from the NHIA self-pay-difference medical device price lookup (queried October 2026), summarized by IOL class as the median per-eye charge; no individual hospital, clinic or brand is listed. Standard monofocal (spherical) IOLs are fully covered by NHI — no out-of-pocket cost. If you choose a special-function IOL, NHI still pays 2,744 points toward the lens and you pay the difference shown below; the cataract surgery itself is covered by NHI.

Scroll horizontally to read the table. With a keyboard, focus the table area and use the arrow keys.

Class (per eye)	Median charge
Standard monofocal (spherical)	Fully NHI-covered, no out-of-pocket cost
Aspheric monofocal	NT$ 30,500
Aspheric monofocal + astigmatism correction (toric)	NT$ 45,000
Short-range extended focus (enhanced monofocal)	NT$ 40,000
Short-range extended focus + toric	NT$ 55,000
Multifocal – bifocal	NT$ 60,000
Multifocal – bifocal + toric	NT$ 90,000
Long-range extended depth of focus (EDOF)	NT$ 75,000
Long-range EDOF + toric	NT$ 98,000
Multifocal – trifocal	NT$ 85,000
Trifocal + toric	NT$ 110,000

Amounts are the per-eye IOL difference only and exclude surgery (NHI-covered); listed amounts are the median charge for each class; actual charges vary by hospital/clinic and may be higher or lower than listed.

Source: NHIA (Taiwan National Health Insurance Administration) self-pay-difference medical device price lookup (queried October 2026). For reference only; actual charges follow each hospital/clinic's posted fee schedule.

Postoperative medications: NHI coverage (rules updated 22 October 2026)

§14.4.1 ophthalmic quinolones (moxifloxacin/levofloxacin): limited to corneal ulcer or severe keratitis; for other eye conditions they are second-line drugs and a bacterial sensitivity report must accompany the claim. Discuss postoperative prophylaxis with your doctor
§14.8 ophthalmic ketorolac (topical NSAID): covered only for ocular inflammation after cataract surgery
(Section 14 of the rules sets no specific coverage restriction for ordinary postoperative steroid drops such as dexamethasone, prednisolone and loteprednol)

💡 Budget-friendly alternatives

Option 1 (cheapest): standard spherical IOL (NHI-covered) + post-op cylinder glasses → astigmatism corrected by glasses
Option 2: standard IOL + simultaneous LRI (some centers offer, may be bundled) → partial astigmatism correction, may still need some glasses
Option 3: toric IOL with an out-of-pocket difference (monofocal toric ~NT$ 45,000 per eye, cheaper than multifocal toric at NT$ 90,000–110,000) → astigmatism corrected by IOL

Key point: don't choose 'upgrade' IOLs just because the name sounds premium. Base the decision on your actual corneal astigmatism, lifestyle, budget, and individualized discussion with your doctor.

Further reading: this article focuses solely on toric IOL. For overall cataract surgery decisions (modality, IOL classification, monovision, NHI vs self-pay, scenarios), see Cataract Surgery Selection. For basic cataract knowledge (what is cataract, when to operate, preoperative prep), see Cataract Surgery Patient Education.

14. 5 common myths

Myth 1: 'Anyone with astigmatism should get a toric IOL for cataract surgery'

Fact: astigmatism < 0.75 D usually does not need a toric IOL; the benefit is small. 0.75–1.0 D is a grey zone; ≥ 1.0 D can be considered, with the clearest benefit above 1.5–2.0 D. The decision depends on astigmatism magnitude, regularity, tolerance for glasses, and budget. Don't pick the priciest option because of clinic sales talk.

Myth 2: 'A toric IOL guarantees no more glasses'

Fact: toric IOLs raise the chance of going glasses-free but do not guarantee it; even with multifocal toric IOLs, about 5% (distance) and 21% (near) of patients in Visser et al. 2011 still needed glasses. Cochrane meta-analyses show ~70% achieve residual < 0.5 D, meaning ~30% have ≥ 0.5 D residual and may need mild glasses. Different tasks (reading, phone, night driving) have different needs. Toric IOL substantially reduces glasses dependence but doesn't guarantee zero glasses.

Myth 3: 'After a toric IOL you can never have a laser touch-up'

Fact: yes you can. If significant residual cylinder or sphere remains after 3 months, options include LASIK enhancement, PRK; larger errors can be addressed with IOL exchange or piggyback IOL. Abroad, the Light Adjustable Lens (LAL) allows postoperative UV-light adjustment but must be implanted at the original surgery; no Taiwan MOHW license could be found, so it is not yet available in Taiwan. Discuss with the original surgeon.

Myth 4: 'Self-pay toric IOLs must be safer or higher quality than NHI standard IOLs'

Fact: the out-of-pocket cost reflects added astigmatism-correction value, not 'overall higher IOL safety.' Standard spherical IOLs perform their core cataract function safely and effectively. Toric IOLs add astigmatism correction but also add complexity (precise alignment, very rare repositioning). If your astigmatism is small, budget is limited, and you accept glasses, standard IOL is entirely reasonable.

Myth 5: 'IOL rotation means the surgeon was bad'

Fact: rotation is multifactorial — beyond intraoperative alignment, it's affected by IOL design (haptic shape, material), IOL-to-bag size matching, capsulorhexis size, residual viscoelastic, patient behavior, capsular fibrosis pattern, PEX or other pathology. Even the most experienced surgeon with the most advanced image-guided system and the newest hydrophobic acrylic IOL has a 0.5–3% rotation rate. The key is early detection and timely repositioning — most repositioning is done within 1 to a few weeks after surgery (about 10 days on average in Oshika's study); waiting too long makes it harder once capsular fibrosis sets in. If your vision is below expectations after surgery, tell your ophthalmologist to check IOL alignment.

15. Advanced topics: open questions and future directions

Verstraaten et al. honestly list open questions in toric IOL practice for the curious reader:

Cost-effectiveness evidence is sparse: health-economic analyses comparing toric IOL vs LRI or no correction in 'long-term glasses savings, reduced secondary procedures, QoL gains' are few. This matters for policy and insurance decisions
Long-term (≥ 5 yr) PROM data lacking: most studies follow only 6 months to 2 years; longer-term visual quality, satisfaction, and QoL need extended follow-up
Indications for irregular astigmatism remain ill-defined: mild irregularity (mild KC, mild post-LASIK irregularity, borderline dry eye) — RCT evidence for toric IOL applicability is scarce
Low astigmatism (0.75–1.5 D) toric IOL benefit: Buscacio et al. 2016 (small study) showed benefit in low cylinder, but large RCT confirmation lacking; ESCRS is running the TORIC Study (predicted residual astigmatism 0.75–1.50 D) to address
Image-guided vs manual alignment cost-effectiveness: image-guided's superior precision is established, but 'equipment cost vs accuracy gain' value-for-money analyses are limited
Surgeon education and standardization: toric IOLs turn cataract surgery into refractive surgery, requiring corneal astigmatism evaluation, precise alignment, and touch-up skills. Society guidelines are evolving; practice variation persists

16. Summary: 5 questions to ask your doctor

💬 5 questions to ask at your consultation

'What is my corneal astigmatism in diopters? Is it WTR, ATR, or oblique? Regular or irregular?'
'For my level of astigmatism, do you recommend toric IOL, LRI, or standard IOL + glasses? Why?'
'What's the estimated residual astigmatism after surgery? Will I need glasses? What will distance vs near be like?'
'What's your intraoperative alignment method — manual marking or image-guided? What's your repositioning rate for toric IOLs?'
'I have (post-LASIK / KC / PEX / Fuchs, etc.) — does this affect my toric IOL options and outcomes? Which formula will you use?' (Tailor to your situation)

Closing: by 2026, toric IOLs have moved from 'premium option' to 'mainstream recommendation for moderate-to-high astigmatism cataract patients.' International reviews confirm that with well-selected patients, precise preoperative measurement, appropriate formulas, and accurate intraoperative alignment, toric IOLs are safe and effective, substantially improving postoperative UDVA and quality of life. But this isn't a panacea — residual astigmatism isn't zero, very rare cases need repositioning, the out-of-pocket difference in Taiwan is non-trivial (typically ~NT$ 45,000 per eye for a monofocal toric), and irregular astigmatism and special populations still need careful assessment. The final decision is always an individualized 'your astigmatism + your lifestyle + your budget + your surgeon's judgment.' Wishing you a clear, comfortable visual recovery.

References

Verstraaten JWH, Buzzi M, Masalkhi M, Behndig A, Cochener B, Day AC, Dick HB, Findl O, Lapid-Gortzak R, Kohnen T, Nuijts R, Rosen P, van den Biggelaar FJHM, Abulafia A, Virgili G, Dickman MM. Correcting Astigmatism Using Toric Intraocular Lenses During Cataract Surgery. Am J Ophthalmol. 2026;286:248–262.
Kessel L, Andresen J, Tendal B, et al. Toric intraocular lenses in the correction of astigmatism during cataract surgery: a systematic review and meta-analysis. Ophthalmology. 2016;123(2):275–286.
Lake JC, Victor G, Clare G, et al. Toric intraocular lens versus limbal relaxing incisions for corneal astigmatism after phacoemulsification. Cochrane Database Syst Rev. 2019;12:CD012801.
Al-Mohtaseb Z, Steigleman WA, Pantanelli SM, et al. Toric monofocal intraocular lenses for the correction of astigmatism during cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology. 2024;131(3):383–392.
Hashemi H, Fotouhi A, Yekta A, et al. Global and regional estimates of prevalence of refractive errors: systematic review and meta-analysis. J Curr Ophthalmol. 2018;30(1):3–22.
Day AC, Dhariwal M, Keith MS, et al. Distribution of preoperative and postoperative astigmatism in a large population of patients undergoing cataract surgery in the UK. Br J Ophthalmol. 2019;103(7):993–1000.
Koch DD, Ali SF, Weikert MP, et al. Contribution of posterior corneal astigmatism to total corneal astigmatism. J Cataract Refract Surg. 2012;38(12):2080–2087.
Abulafia A, Barrett GD, Kleinmann G, et al. Prediction of refractive outcomes with toric intraocular lens implantation. J Cataract Refract Surg. 2015;41(5):936–944.
Oshika T, Inamura M, Inoue Y, et al. Incidence and outcomes of repositioning surgery to correct misalignment of toric intraocular lenses. Ophthalmology. 2018;125(1):31–35.
Hoffmann P, Potvin R, Anello RD, et al. Comparing rotational stability over time between four monofocal toric intraocular lenses. Clin Ophthalmol. 2025;19:1345–1355.
Lee BS, Chang DF. Comparison of the rotational stability of two toric intraocular lenses in 1273 consecutive eyes. Ophthalmology. 2018;125(9):1325–1331.
Singh VM, Ramappa M, Murthy SI, et al. Toric intraocular lenses: expanding indications and preoperative and surgical considerations to improve outcomes. Indian J Ophthalmol. 2022;70(1):10–23.
Pusnik A, Petrovski G, Lumi X. Dysphotopsias or unwanted visual phenomena after cataract surgery. Life (Basel). 2022;13(1):53.
Abulafia A, Hill WE, Koch DD, et al. Accuracy of the Barrett True-K formula for intraocular lens power prediction after laser in situ keratomileusis or photorefractive keratectomy for myopia. J Cataract Refract Surg. 2016;42(3):363–369.
Wan KH, Chang JSM, Jhanji V. Toric intraocular lenses for astigmatism correction after keratoplasty in phakic and pseudophakic eyes. J Cataract Refract Surg. 2022;48(9):1078–1087.
Yahalomi T, Achiron A, Hecht I, et al. Refractive outcomes of non-toric and toric intraocular lenses in mild, moderate and advanced keratoconus: a systematic review and meta-analysis. J Clin Med. 2022;11(9):2456.
Yen WT, Weng TH, Lin TY, et al. Femtosecond laser-assisted astigmatic keratotomy versus toric IOL implantation for correcting astigmatism in cataract patients: a systematic review and meta-analysis with trial sequential analysis. Br J Ophthalmol. 2025;109(3):324–332.
Mencucci R, Giordano C, Favuzza E, et al. Astigmatism correction with toric intraocular lenses: wavefront aberrometry and quality of life. Br J Ophthalmol. 2013;97(5):578–582.
Zheng J, He L, Zhong J. Effect of femtosecond laser-assisted arcuate keratotomy versus toric intraocular lens implantation on correction of astigmatism in cataract surgery: a systematic review and meta-analysis. Lasers Med Sci. 2023;38(1):225.

Toric IOL for Cataract — Is It Worth It? Who, How Well, What Risks

1. Common clinic scenarios

2. Common patient Q&As

3. Key takeaways: 8 things you really need to know

30-second takeaways

4. Astigmatism and cataract: background

5. Indications and exclusions: who's a candidate?

6. Preoperative workup SOP

7. IOL calculation formulas: which is most accurate?

8. Outcomes and patient-reported satisfaction

9. Toric IOL vs LRI vs FSAK: how to choose?

10. Toric IOL design, material, and intraoperative alignment

11. Rotational stability, repositioning timing, other complications

12. Special populations

(1) Post-refractive surgery (LASIK / SMILE / PRK)

(2) Keratoconus

(3) Pseudoexfoliation syndrome (PEX)

(4) Post-keratoplasty (PK / DALK)

(5) Fuchs endothelial dystrophy + triple DMEK

13. Taiwan context: NHI vs self-pay structure

14. 5 common myths

15. Advanced topics: open questions and future directions

16. Summary: 5 questions to ask your doctor

References

Related reads

Toric IOL for Cataract — Is It Worth It?
Who, How Well, What Risks